Skip to main content
. 2016 Sep 25;22(3):382–389. doi: 10.3350/cmh.2016.0047

Figure 2.

Figure 2.

Cumulative incidence of clinical relapse according to the baseline serum HBeAg level (A), baseline serum HBV DNA level (B), and end-of-treatment HBsAg level (C).